
Weight-loss jabs may need to be taken for life, experts warn
Weight-loss jabs may have to be used for many years if the long-term benefits to patients and the NHS are to be realised, experts have said.
The drugs are sold under brand names like Mounjaro and Wegovy and work by reducing food cravings.
Obese patients can currently be prescribed the jabs on the NHS after being referred to specialist weight loss clinics, which are usually located in hospitals.
Hundreds of thousands of people also access the medication privately at pharmacies.
There have been warnings about buying potentially unsafe jabs online from unregulated retailers and potentially missing out on wraparound support.
Experts said the jabs should not be seen as the first option in weight loss and should be used in conjunction with lifestyle changes, such as eating more healthily and increasing exercise.
Professor Graham Easton, a GP who has been using weight loss jabs himself, said: 'I think it's a major issue about the proper funding and resourcing of not only the GPs in the surgeries but also the wraparound care we talked about.
'I think the other issue is that so far, to my knowledge, the NHS and National Institute for Health and Care Excellence have talked about this being something you take for two years, and that's probably related to data from research studies.
'But as we discussed, this is likely to be a lifelong commitment if it is going to be worthwhile to the NHS.
'There's no point in most people taking it for a couple of years and then have the weight bouncing back.
'You can argue possibly you're about to prepare for surgery or something, but in most cases it doesn't make any sense.
'Then I think there's a big issue around access. Most obesity occurs in poorer populations as wealthier populations tend to not be so affected.
'There's a massive sort of socio-economic inequality and there is a worry about this driving that inequality even further.
'Unless the NHS makes sure that these are available across the board equally, I think that's a major risk.'
Prof Easton said recent studies had shown people who stopped taking the drugs had put the weight they lost back on within around a year.
'That's often true of any diet, people would say, and that's certainly my experience of having wrestled with my weight in diets over the years,' he said.
'All I would say that I found interesting from that review was that they were suggesting perhaps that weight returns even quicker after having been on GLP-1 drugs.
'Then speculating, because there was no way of knowing from that review, that perhaps it's because people are not changing the behaviours we've been talking about like exercise and other lifestyle changes, just relying on the drugs.
'When you stop them, of course, you're going to put weight back on. The switch is turned back off, or whatever it was.
'I mean very similar to, for example, statins or anti-hypertensive blood pressure medications, if you want lifelong effects, you have to keep on them lifelong.'
Prof Easton was speaking at an event at the Cheltenham Science Festival discussing the growing use of weight loss drugs with neurophysiologist Dr Simon Cork and consultant endocrinologist and obesity expert Dr Tony Goldstone.
Dr Cork said the jabs have an important role to play in losing weight but are part of wider changes to diet and lifestyle.
'I think we have to understand that diet is always limited. People will tend to lose on average around 5% of their body weight on a diet,' he said.
'But you're hungry, you're miserable, you're tired, your wife hates you because you're so grumpy, you're not going to continue with that.
'But we should absolutely all be looking at our diet and all changing our diet, and doing something.'
Dr Goldstone said weight loss drugs had been used in the treatment of diabetes for over a decade and had benefits of reducing the risk of developing other conditions.
'We're now in the third and fourth generation of these drugs, but the first generation of these drugs we've been using for 15 years for diabetes,' he said.
'There is nothing of concern that has emerged. In fact, all we're seeing are benefits. I'm not too worried about longer term side effects coming out.
'There is no real biological reason why there should be dangerous side-effects in the way that we know these drugs work.
'The benefits of the weight loss improvement in the diabetes are actually by themselves helping health and preventing other diseases, like cancer, heart attacks, renal failure, and potentially even reducing the risk of Alzheimer's disease.
'All those benefits, even if there was something that we hadn't really thought of that emerged down the line, I suspect that the harm of that is outweighed by the potential benefits of weight loss improvement in diabetes control.'
Dr Cork said no drug is without side-effects and previous weight loss medications had failed because of them.
'There are side-effects, there are some concerning side-effects that tend to be very rare, but then you can monitor for those side-effects,' he said.
'As long as you're getting the correct care, as long as your GP is aware that you're taking them, then those should be identified.
'If you do find those side-effects, you can stop taking the drug.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
an hour ago
- The Independent
Chancellor unveils £6bn NHS funding after health-centred spending review
Some £6 billion will be spent on speeding up testing and treatment in the NHS, Rachel Reeves has announced, after she placed the health service at the heart of Government spending plans. The Chancellor unveiled the investment, which includes new scanners, ambulances and urgent treatment centres aimed at providing an extra four million appointments in England over the next five years, after Wednesday's spending review. The funding is aimed at reducing waiting lists and reaching Labour's 'milestone' of ensuring the health service carries out 92% of routine operations within 18 weeks. In the review, Ms Reeves set out day-to-day spending across Government for the next three years, as well as plans for capital investment over the next four years. The NHS and defence were seen as the winners from the settlement, as both will see higher than average rises in public spending. This comes at cost of squeezing the budgets of other Whitehall departments and experts have warned tax rises may be needed later this year. The Chancellor and Sir Keir Starmer both sought to portray the review as a 'new phase' for the Government, following the criticism Labour has faced during its first year in power, including over cuts to winter fuel allowance. Ms Reeves claimed the NHS had been 'put on its knees' as a result of under-investment by the previous government, adding: 'We are investing in Britain's renewal, and we will turn that around.' The new £6 billion investment will come from the capital settlement for the NHS and will also help to speed up diagnoses with scans and treatment available in places such as shopping centres and high streets. The scale of day-to-day spending for the NHS is akin to an extra £29 billion a year. In a broadcast interview on Wednesday evening, Ms Reeves said the Government was 'confident' it could meet its pledge to reduce waiting lists after the boost to NHS spending. But while health and defence have benefited from the review, the Home Office, Ministry of Housing, Communities and Local Government, Department for Culture, Media and Sport, Department for Transport and Department for the Environment, Food and Rural Affairs are all in line for real-terms cuts in day-to-day spending. The Foreign Office is also in line for real-terms cuts, mainly as a result of a reduction in the overseas aid budget, which was slashed as part of the commitment to boost defence spending to 2.6% of gross domestic product – including the intelligence agencies – from 2027. Ms Reeves acknowledged 'not everyone has been able to get exactly what they want' following Cabinet squabbling over departmental budgets. She said 'every penny' of the spending increases had been funded through the tax and borrowing changes she had announced in her first budget. The Chancellor also insisted she would not need to mount another tax raid to pay for her plans, but experts warned the money for the NHS might still not be enough and the Government is under international pressure to boost defence funding further. Paul Johnson, of the Institute for Fiscal Studies, described the hospital waiting times target as 'enormously ambitious', adding: 'And on defence, it's entirely possible that an increase in the Nato spending target will mean that maintaining defence spending at 2.6% of GDP no longer cuts the mustard.' At a summit later this month Nato members will consider calls to increase spending to 3.5% on defence, with a future 1.5% on defence-related measures. Steven Millard, interim director of the NIESR economic research institute, said the Chancellor's non-negotiable fiscal rules, coupled with the 'small amount of headroom' in her spending plans, meant 'it is now almost inevitable that if she is to keep to her fiscal rules, she will have to raise taxes in the autumn budget'. Elsewhere, policing leaders warned forces may need to make deep cuts after their settlement was announced. The spending review provides more than £2 billion for forces, but ministers have acknowledged some of that 'spending power' will come from council tax hikes.


Scottish Sun
an hour ago
- Scottish Sun
Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z
Doctors say heavy use can cause liver disease and permanently damage the bladder and kidneys GENERATION K Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z DOCTORS have sounded the alarm over an eight-fold rise in ketamine addiction in a decade. The powerful tranquilliser is popular with Generation Z because of its relatively low cost, experts say. Advertisement 1 Addiction to ketamine has risen eight-fold in a decade, experts have warned Credit: Getty Clinics in England treated 3,609 people of all ages for addiction last year, eight times more than 426 in 2014, figures reveal. Ketamine, also referred to as 'K' or 'Ket', numbs pain and can cause a trippy high. Dealers sell it in powder form for around £20 to £40 a gram compared with £40 to £60 a gram for low-quality cocaine. Doctors say heavy use can cause liver disease and permanently damage the bladder and kidneys. It is linked to constipation, depression and loss of mental sharpness. Advertisement Many medics fail to understand how addictive it can be, an NHS report said. Led by Dr Irene Guerrini of the South London and Maudsley NHS Trust, it called the drug's prevalence 'concerning'. It said: 'As ketamine use increases, more individuals are seeking treatment for addiction. 'Long-term use can seriously harm both physical and mental health, diminishing quality of life, affecting personal relationships and impairing academic or professional performance.' Advertisement Dr Guerrini called for stricter guidelines on how the NHS uses the drug and more funds for treatment and prevention. Ministers are considering uprating 34878330from a Class B to Class A drug.


The Sun
an hour ago
- The Sun
Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z
DOCTORS have sounded the alarm over an eight-fold rise in ketamine addiction in a decade. The powerful tranquilliser is popular with Generation Z because of its relatively low cost, experts say. Clinics in England treated 3,609 people of all ages for addiction last year, eight times more than 426 in 2014, figures reveal. Ketamine, also referred to as 'K' or 'Ket', numbs pain and can cause a trippy high. Dealers sell it in powder form for around £20 to £40 a gram compared with £40 to £60 a gram for low-quality cocaine. Doctors say heavy use can cause liver disease and permanently damage the bladder and kidneys. It is linked to constipation, depression and loss of mental sharpness. Many medics fail to understand how addictive it can be, an NHS report said. Led by Dr Irene Guerrini of the South London and Maudsley NHS Trust, it called the drug's prevalence 'concerning'. It said: 'As ketamine use increases, more individuals are seeking treatment for addiction. 'Long-term use can seriously harm both physical and mental health, diminishing quality of life, affecting personal relationships and impairing academic or professional performance.' Dr Guerrini called for stricter guidelines on how the NHS uses the drug and more funds for treatment and prevention. Ministers are considering uprating 34878330from a Class B to Class A drug.